Application Version: 4.0.6.10
Content Version: 2024.07.12
Release Notes [PDF288KB]
User Guide [PDF6.08MB]
Code System Update Calendar
Contact Us
Subscribe
Related Links
- PHIN Vocabulary Services
- Quick Links / Mapping Tools
- External Standards Resources
- Message Guides
- Developer's Guide
- PHINVADS FHIR API
Downloads
- RCMT Quick Search
Value Set Information
|
- Value Set Concepts
- Value Set Details
|
||||||
Concept Code | Concept Name | Preferred Concept Name | Code System | Value Set | ||
---|---|---|---|---|---|---|
24 | anthrax | anthrax vaccine | Vaccines administered (CVX) | Vaccine Type (NND) | Details | |
181 | anthrax immune globulin | anthrax immune globulin | Vaccines administered (CVX) | Vaccine Type (NND) | Details | |
19 | BCG | Bacillus Calmette-Guerin vaccine | Vaccines administered (CVX) | Vaccine Type (NND) | Details | |
27 | botulinum antitoxin | botulinum antitoxin | Vaccines administered (CVX) | Vaccine Type (NND) | Details | |
173 | cholera, BivWC | cholera, BivWC | Vaccines administered (CVX) | Vaccine Type (NND) | Details | |
174 | cholera, live attenuated | cholera, live attenuated | Vaccines administered (CVX) | Vaccine Type (NND) | Details | |
26 | cholera, unspecified formulation | cholera vaccine, unspecified formulation | Vaccines administered (CVX) | Vaccine Type (NND) | Details | |
172 | cholera, WC-rBS | cholera, WC-rBS | Vaccines administered (CVX) | Vaccine Type (NND) | Details | |
211 | COVID-19 vaccine, Subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL | SARS-COV-2 (COVID-19) vaccine, Subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 0.5mL per dose | Vaccines administered (CVX) | Vaccine Type (NND) | Details | |
212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-Ad26, preservative free, 0.5 mL | Vaccines administered (CVX) | Vaccine Type (NND) | Details | |
210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-ChAdOx1, preservative free, 0.5 mL | Vaccines administered (CVX) | Vaccine Type (NND) | Details | |
207 | COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5 mL dose | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 100 mcg/0.5mL dose | Vaccines administered (CVX) | Vaccine Type (NND) | Details | |
208 | COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose | Vaccines administered (CVX) | Vaccine Type (NND) | Details | |
56 | dengue fever | dengue fever vaccine | Vaccines administered (CVX) | Vaccine Type (NND) | Details | |
12 | diphtheria antitoxin | diphtheria antitoxin | Vaccines administered (CVX) | Vaccine Type (NND) | Details |
- Page last reviewed:June 20, 2024
- Page last updated:June 20, 2024
- Content source: